chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swelling in between 2nd and 3rd digits of the right hand; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in between 2nd and 3rd digits of the right hand) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling in between 2nd and 3rd digits of the right hand). At the time of the report, PERIPHERAL SWELLING (swelling in between 2nd and 3rd digits of the right hand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
my arm was sore; fever; chills; booster; This is a spontaneous report from a contactable consumer or other non hcp. A 64-years-old female patient received third dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 09Nov2021 15:00 (at the age of 64-years-old) as dose 3 (booster), single for covid-19 immunisation. Medical history included Diabetes, Blood pressure and High Sugar. The concomitant medications were not reported, the patient reported that she takes medicine for high sugar and blood pressure and Diabetes. The patient received first and second dose of COVID-19 (Primary Immunization series complete but unknown manufacturer) Vaccine on unknown dates for covid-19 immunisation. On 09Nov2021 at 15:00 the patient experienced booster. On 09Nov2021 at 21:00 the patient experienced fever and chills. On 10Nov2021 the patient experienced my arm was sore. The patient underwent lab tests and procedures which included body temperature: unknown result on an unknown date. Therapeutic measures were taken as a result of fever, chills and my arm was sore. She received a booster dose of the Comirnaty vaccine on 09Nov2021 at 3 PM. By 9 PM she stated she had a fever and chills, she stated she took Tylenol and it went away but she feels like the symptoms were returning. She wants to know if she would be contagious after receiving a booster dose. Treatment included Tylenol. She thinks it was 800. LOT number of Vaccine: she stated, was that on my card 32O3O8B. LOT# 32 either D or O3O8D. She stated she received her Comirnaty booster dose on Tuesday that was 09Nov2021 and she received that 09Nov2021 that was on Tuesday two days ago and that evening she received the shot 3 in afternoon and by 9 PM in the evening she had fever and chills and she called in to medical information to ask some medical question. She reported that her arm was sore on Wednesday but today it was not. She got the COVID Pfizer vaccine Booster. The outcome of the evets fever and chills was not resolved, for the event my arm was sore the outcome was resolved on an unknown date in 2021. The lot number for the vaccine, [Comirnaty], was not provided and will be requested during follow up.
given only the diluent; given only the diluent; This case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix .5 ml. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 07-JUL-2022 Reporter's Comment: The patient was given only the diluent so they had to come back in to get the entire vaccine. The patient had asked the customer for more info a couple times, this was all she gave him/her, but he/she was leaving for vaca tomorrow and he/she knew that he/she had to report it. Additional Supportive Information: The patient was given only the diluent so they had to come back in to get the entire vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
On the day of the second vaccine dose patient was noted to have a large bruise on left upper arm from the first dose 3 weeks ago. Denied pain. No redness.
Rt arm hot, swollen, sl fever, throbbing x 3 days. 11/20 - looked at arm - still red, some swelling, but states better since 11/17.
This spontaneous report as received from a medical assistant refers to a 26 year old patient. No information about the patient's medical history, concurrent conditions and concomitant medications was reported. On an unknown date, the patient was vaccinated with GARDASIL 9 injection, for prophylaxis (dose, lot number and expiration date were not reported). No adverse event was reported.
No adverse effects reported.; patient received improperly stored PROQUAD; Information was received from a nurse referring to an female child. Information about pertinent medical history, concurrent conditions, concomitant medication and drug reactions/allergies was not provided.  On 17-APR-2019, the patient received improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (therapy type: recombinant Human albumin (rHA); lot # R024020 with expiration date 19-FEB-2020; lot # R022574 with expiration date 04-FEB-2020; strength, dose detail and route were not provided) for prophylaxis (product storage error). The measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was reconstituted with properly stored sterile diluent (lot & expiration date was unknown by reporter).   The vaccines were exposed to temperature excursion of 6 fahrenheit degree to 14 fahrenheit degree (also reported as 9.1 fahrenheit degree) for 45 minutes. The vaccines were exposed to previous temperature excursion of 6 degree Celsius to 14 fahrenheit degree (also reported as 11.28 fahrenheit degree) for 15 minutes. No adverse effects reported. Data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA010532: US-009507513-1904USA008214: US-009507513-1904USA010533: US-009507513-1904USA010534: US-009507513-1904USA010535:
I got COVID-19 and my throat was sore and I was really tired and kind foggy. I didn't feel good.  It felt like a bad cold.
Felt bad the next morning, headaches, and significant tooth pain that continued for 4-5 days. Went to dentist on Friday 10/8, who confirmed there was nothing wrong with my teeth. The pain subsided on day 6.
Information has been received from a physician concerning a 5 year old patient with no history who on 10-MAY-2007 was vaccinated with 0.5 ml dose of ProQuad (Lot # 657297/0429U). There were no concomitant medication. On approximately 10-MAY-2007 the patient experienced fever, vomiting and rash. It was reported the patient had symptoms the night after vaccination and was seen in the office on approximately 11-MAY-2007 and received IV fluids due to dehydration. At the time of report, the patient was not recovered. No diagnostic laboratory procedures were undertaken. A product quality complaint was not involved. Additional information will be provided if available. This is one of several reports received from the same source.
Patient started feeling lightheaded and fainted.  Patient was responsive within seconds. The ambulance was called and he was taken away responsive.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concomitant therapy, drug reactions and allergies were not provided. On an unknown date, the patient was vaccinated with improperly stored PROQUAD (rHA) (dose not reported) lot # M011664 with expiration date 08-SEP-2017, subcutaneously for prophylaxis. No adverse effects were reported. No product quality complaint was involved. Follow-up information has been received on 30-NOV-2016 from the medical assistant. The patient was vaccinated with improperly stored doses of PROQUAD on 18-DEC-2011 and on 15-SEP-2016. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1610USA008441: US-009507513-1610USA008442: US-009507513-1610USA008443: US-009507513-1610USA008444: US-009507513-1610USA008445: US-009507513-1610USA008446: US-009507513-1610USA008447: US-009507513-1610USA008448: US-009507513-1610USA008449: MERCK 1609USA010309:Mfr number.
At 8pm day of the vaccine patient starting running low grade fever (100.5) and had a headache and nausea. At 5am 7/11/19 she started projectile vomiting. Her mom gave her Phenergan and it helped until 8am when she woke up and continued to projectile vomit. She still had the headache. Mom said she could not stop the vomiting. She called to ask us about side effects and we discussed them, but hers were not just mild problems. Mom was concerned about her becoming dehydrated. She took her to the E.R where they gave her fluids, Zofran and put her on a clear liquid diet for a day. The next day she was feeling better.
Pt. states started getting red & sore the same day - by the next day it was very hot, red & sore to touch. Had hard knot about 1-1 1/2" wide - occas. throbbing pain. MD visit 3 days post injection.
Within a few hours of getting vaccine pt felt shaky. Headache, stomachache, felt warm. Last vaccine done 2-27-07 some reaction. Felt better after 2 days
Received Moderna booster on 11-17-21. Covid symptoms started 12-27-21. Tested positive 12-31-21.
Reaction after her CT. #3 Hep B vaccine given 10/29/01. Check out hot flashes, hives, dizziness and red bruised. CT area at injection site. Symptoms occurred that same evening.
This spontaneous report was received from a pharmacist referring to a pharmacy technician of unknown age and gender. Medical history, concurrent conditions concomitant medications were not reported. On an unknown date, the pharmacy technician suffered an accidental topical to exposure to the powder from ZOSTAVAX, 19400 unit 1 standard package vial of 1, lot # K018175 and expiration date in January 2016, that may have been leaking. The pharmacist reported also that ZOSTAVAX was stored at room temperature, as it had already been pulled from the freezer some time ago, and was slated for return to the distributor (incorrect product storage). No adverse events were reported and Product Quality Control (PQC) was filled on 18-NOV-2015. This is one of two reports received from the same source (MARRS # 1511USA009847). Additional information has been requested.
Fever 101.4. Headache body aches diarrhea ongoing for 3 days now
While in observation, patient reports stomach cramping and lightheadedness. Pt provided a snack and vital signs continuously monitored. Pt. declined wanting to go to ED/UC. After about 40 minutes, patient reports lightheadedness and stomach cramping improving. Patient states he feels okay to go home and states his mom is driving him. Pt. given precautions to return to ER if symptoms worsened.
mild fever; stiffness (back as well as arms); 2.5 days of fatique; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (at the age of 33 years old; batch/lot number and expiration date not reported) as first dose, single dose and via an unspecified route of administration, administered in the left arm on an unspecified date (at the age of 33 years old; batch/lot number and expiration date not reported) as second dose, single dose, both for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced 2.5 days of fatique, mild fever, and stiffness (back as well as arms) on an unspecified date. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
On Monday 4/11/11, patient called to report symptoms at 7:32 pm.  Message was received the next morning, and called the patient at 11:40 am 4/12/11.  Patient returned call at about 5:45 pm on the same day.  He reported having received HPV Vaccine #2 on 4/7/11, felt fine that day.  About 24-30 hours later, developed muscle pain in the bilateral lower trapezius and gluteal area, Left-sided joint stiffness.  The next day he got up and felt fine x two hours, then developed extreme fatigue.  Complained of ear swelling and redness.  Finally developed palpitations, so went to a walk-in clinic (not identified).  Per clinic doc, reported that the patient was physically stable, but stated that in a "recent study on vaccines for women" several women came in with similar complaints, and recommended that he report this to the study staff.  The next day, he developed one loose bowel movement.  Denied nausea or vomiting or fever.  Slight headache was present. Slowly all of his symptoms have dissipated, and he feels almost normal on the day of the call.  Of note, the patient reported that he felt presyncopal during the injection of the 1st dose, however, felt fine at the time of the 2nd dose. I attempted to call participant on 4/18/11 around 10 am-message left on voice mail. No treatment was given.
throat swollen couldn't swallow; eyes real real red & hurt; felt had something in throat around noon; 430 felt real weak from waist down-would fall if tried to walk; chills-shaking so cold couldn't warm up;
Temperature spiked, didn't measure but guessing around 102. Alternated between chills and hot flashes. Strong headache. Some balance issues. Basically, incapacitated me to the point where all I could do was lay in bed and wait it out. Headache persisted the next day, although not as strong. I had COVID last December (thankfully short--a couple of days) and these symptoms were almost identical. A year or so ago I got the original Moderna shot and did not have any issues.
patient states she woke up on 5/25 she had a rash on her chest and face and her lips and mouth  felt tingly.  She states the rash is sore to the touch and not itchy.  She took a benadryl right away and she states the mouth feeling improved. She will continue on benadryl until symptoms resolve and also is using hydrocortisone 1% topical on the rash.
This spontaneous report as received from a medical assistant via field representative referred to herself, who was a female patient of unknown age. Patient reported that when she received ZOSTAVAX (Lot#, dose/frequency, route and duration were unspecified) on an unknown date, she had a "terrible migraine the next morning." Patient turned the lights off and rested the day until the migraine subsided later that day. Patient did not seek medical attention, no treatment was given for the event. The outcome of terrible migraine was reported as recovered(date unspecified). Drug relationship was not provided. Additional information has been requested.
I received my Moderna Bivalent booster at approximately 4:00 p.m. on 10/28/22.  I then received my Fluzone HD 65+ vaccine at approximately 4:45 p.m.  Around 9:00 p.m. that evening I started getting a fever blister on my lip.  I had a prescription medication (Valacyclovir) on hand and started taking that.  I continued taking through 10/31/22 at which time I started getting another fever blister. I continued for 2 days on the Valacyclovir at which time they had gone away.   I also developed a cough that began on 11/1/22.  That cough worsened - continuous coughing, not coughing up anything, not wheezing.  I visited my family doctor on 11/2/22 and was given Tessalon Perles and advised to start using my nebulizer with Albuterol and Ipratropium every 4-6 hours along with OTC cough medicine.  This cough continued and I visited my doctor again on 11/4.  At this time I was given Robitussin AC and a Flovent inhaler to add to my medications to try to stop the cough.  By 11/5/22 I was barely coughing and feeling better. I have stopped the nebulizer treatments and Tessalon Perles but continue with the Flovent and Albuterol inhalers daily.  I have only had an occasional dry cough since then.
Case number PHEH2016US033603, is an initial spontaneous report received from a pharmacist on 20 Dec 2016. This report refers to an unknown age of male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with single dose of FLUVIRIN (batch number: not reported) at a dose of 0.5 ml, intramuscularly on 01 Sep 2016. The patient received 02 flu shots for this season and all documentation had been lost. It was reported that, second vaccine administered 02 to 03 months ago (Sept 2016 or Oct 2016). No adverse event reported following this medication error. The case was assessed as non serious by the pharmacist.
Dental pain; Heart problems; Felt like he was going to throw up; His nose is running/sinuses are being attacked; Burning in his arm; Tearing; Extreme headaches and pain; Tired; Constant pain in his eye sockets; Can't even think, the pain is unbearable; Can't even sleep/hurts to lay down; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Can't even think, the pain is unbearable), INSOMNIA (Can't even sleep/hurts to lay down), TOOTHACHE (Dental pain), EYE PAIN (Constant pain in his eye sockets) and CARDIAC DISORDER (Heart problems) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 16B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN (Can't even think, the pain is unbearable), INSOMNIA (Can't even sleep/hurts to lay down), EYE PAIN (Constant pain in his eye sockets), RHINORRHOEA (His nose is running/sinuses are being attacked), BURNING SENSATION (Burning in his arm), LACRIMATION INCREASED (Tearing), HEADACHE (Extreme headaches and pain) and FATIGUE (Tired). On 24-Mar-2021, the patient experienced NAUSEA (Felt like he was going to throw up). On an unknown date, the patient experienced TOOTHACHE (Dental pain) and CARDIAC DISORDER (Heart problems). At the time of the report, PAIN (Can't even think, the pain is unbearable), INSOMNIA (Can't even sleep/hurts to lay down), TOOTHACHE (Dental pain), EYE PAIN (Constant pain in his eye sockets), CARDIAC DISORDER (Heart problems), RHINORRHOEA (His nose is running/sinuses are being attacked) and LACRIMATION INCREASED (Tearing) had not resolved and BURNING SENSATION (Burning in his arm), HEADACHE (Extreme headaches and pain), FATIGUE (Tired) and NAUSEA (Felt like he was going to throw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided. The patient reported that he had a dental cleaning and took ibuprofen.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: F/U-1 : VAERS, medical history, conc meds, AE details and outcome, Batch number of Dose 1 vaccine
redness & swelling around site of vax 24-48hr p/vax;mild improvement noted 3 days later;no fever or tenderness;walking w/problems;
Approximately 3 weeks after receiving the vaccine, I started getting red patches, rash, and blisters on my torso.  It started above my waist on the front of my body, it was very red with blisters.  Then every day it spread; to my back below my waist, then above my waist, and most recently across my stomach.  The rash is itchy and a little painful.  I contacted by physician and she suggested OTC medications and to not get the second dose.
Patient reported that she "got shingles from the vaccine" because she had her first shingles outbreak 4 days after the vaccination on her back.
Information has been received from a nurse referring to unspecified patients of unknown age and gender. The patients' concomitant medication, pertinent medical history and drug reactions/allergies were not provided. On unknown dates the unspecified patients received doses of improperly stored PROQUAD (rHA) (strength, dose, frequency, route were not reported, lot # N031929, expiry date 12-MAY-2019) for prophylaxis. Concomitant therapy included sterile diluent (lot # and expiry date were unknown). Sterile diluent used to reconstitute PROQUAD was stored properly. The temperature and time frame were unknown. There were no previous excursions reported. The call was because of a data logger. No adverse effects were reported. Follow up information was received on 05-SEP-2018 from the nurse and from the physician. The reporters stated that three female children and five male children between the ages of 1 year and 4 years received doses of PROQUAD on an unspecified date in the past 3 months in approximately 2018. The patient was 4 year old male patient. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided. There had been no adverse events following the administration of the improperly stored PROQUAD vaccinations. This was just temperature issue where temperature reached -12 Celsius degree. Sender's Comments: US-009507513-1808USA010810: US-009507513-1809USA004055: US-009507513-1809USA004056: US-009507513-1809USA004058: US-009507513-1809USA004059: US-009507513-1809USA004060: US-009507513-1809USA004061.
Initial unsolicited report received from a physician on 06-JUL-2015. This case is linked to cases: 2014SA151239, 2015SA105624, 2015SA105628 and 2015SA105636 (same vaccine, same reporter and same batch number). All ten patients were vaccinated with FLUZONE ID vaccine on 30-OCT-2014. The individual identifiers were reported. A patient had received a dose of FLUZONE ID via intradermal route (batch number: UT4993BA, expiry date: 06-MAY-2015, dose in series an site of administration were not reported) on 30-OCT-2014. The pre-existing physician diagnosed allergies, birth defects, medical conditions and illness at the time of vaccination was reported as none. Concomitant medications were not reported. On 30-OCT-2014, the patient developed some redness and the site was sore. On an unspecified date, the patient was ill for 2 days and had fever and sever body aches. Laboratory investigations and corrective treatments were not provided. The patient required ER/doctor visit. On an unspecified date, the patient recovered from the event of illness. The outcome for the events of fever, severe body ache, sore and some redness was  not reported. List of documents held by sender: none.
patient stated she was fine after vaccine, then after a few minutes she stated she felt dizzy. before pharmacist could get back around counter to patient, she fainted and slid out of her chair.  patient was alert moments after landing on the floor.  patient was laid out on floor and vitals monitored.  once vitals returned to normal and patient felt better, she was given water and a banana.  EMT arrived and evaluated patient.  patient was taken to hospital per EMT  suggestion.  time frame: 17:26-17:52